StaphOff Biotech
StaphOff Biotech Inc. is an innovative pharmaceutical company dedicated to developing medical products that prevent or stop resistant Staphylococcal infections. They utilize a unique approach with molecules like CEN-101 and CEN-103 that weaken bacteria's ability to resist immune defenses and traditional antibiotics, by inhibiting communication, biofilm formation, and toxin production, thereby enhancing the body's immune response and antibiotic efficacy.
Industries
Nr. of Employees
small (1-50)
StaphOff Biotech
37 Henry Marsh Rd, Dudley, Massachusetts 01571, U.S.A.
Products
whISOBAX tincture
A tannin‑rich plant extract tincture formulated for topical and potential dietary uses; provided in multiple package sizes and claimed to have higher active concentration than standard extracts.
whISOBAX tincture
A tannin‑rich plant extract tincture formulated for topical and potential dietary uses; provided in multiple package sizes and claimed to have higher active concentration than standard extracts.
Services
Provision of a liquid, high‑tannin plant extract for topical, nasal or formulation use, produced in a GMP-certified, FDA-registered facility.
Curated library of peer-reviewed publications and willingness to discuss research related to anti-virulence and anti-biofilm technologies.
Provision of a liquid, high‑tannin plant extract for topical, nasal or formulation use, produced in a GMP-certified, FDA-registered facility.
Curated library of peer-reviewed publications and willingness to discuss research related to anti-virulence and anti-biofilm technologies.
Expertise Areas
- Anti-virulence therapeutics
- Biofilm-targeting therapies
- Preclinical in vivo efficacy testing
- Topical formulation development
Key Technologies
- Quorum sensing inhibition
- Anti-biofilm agents
- Topical and systemic drug formulation
- High-tannin plant extract processing
News & Updates
The Michiana Family YMCA is alerting the public that a staff member, as well as a child attending its Child Watch service, has contracted Methicillin-resistant Staphylococcus aureus, more commonly known as MRSA.
The UN secretary general, Ban Ki-moon, said antimicrobial resistance is a 'fundamental threat' to global health and safety at the first general assembly meeting on drug-resistant bacteria.
Warnings about the approaching post-antibiotics apocalypse have been sounding for years, with strains of bacteria resistant to all antibiotics causing untreatable infections and rising death tolls.
A study finds that secondary infection with MRSA often kills influenza patients because the flu virus alters white blood cells' response, leading to lung damage.
A drug-resistant strain of E.coli bacteria was found in the U.S., carrying the resistance gene Mcr-1, indicating the emergence of resistant bacteria in the community.
The Michiana Family YMCA is alerting the public that a staff member, as well as a child attending its Child Watch service, has contracted Methicillin-resistant Staphylococcus aureus, more commonly known as MRSA.
The UN secretary general, Ban Ki-moon, said antimicrobial resistance is a 'fundamental threat' to global health and safety at the first general assembly meeting on drug-resistant bacteria.
Warnings about the approaching post-antibiotics apocalypse have been sounding for years, with strains of bacteria resistant to all antibiotics causing untreatable infections and rising death tolls.
A study finds that secondary infection with MRSA often kills influenza patients because the flu virus alters white blood cells' response, leading to lung damage.
A drug-resistant strain of E.coli bacteria was found in the U.S., carrying the resistance gene Mcr-1, indicating the emergence of resistant bacteria in the community.